October 07, 2021
Article
The companies made the request after their recent submission of data to support the emergency use authorization (EUA) in this patient population.
October 06, 2021
Qatar has the highest mRNA vaccine coverage in the world, but their vaccinated population is experiencing significant waning in vaccine efficacy, leading to breakthrough infections.
October 05, 2021
US federal health agencies are recommending an additional shot for this diverse patient population, and here on some insights about vaccine efficacy and breakthrough infections in these groups.
This study confirmed reports from the CDC and Israel Ministry of Health that found the Pfizer-BioNTech vaccine waned after 6 months.
October 03, 2021
Video
Monica McArthur, MD, PhD, discusses why to-be-authorized COVID-19 vaccine doses for children may not be tiered for patient risk as they were for adults.
October 01, 2021
Investigators examined asymptomatic infection and the duration of viral shedding in symptomatic breakthrough infections in a phase 3 study with the AZD1222 COVID-19 vaccine.
September 29, 2021
An expert explains the science of vaccine- and infection-induced immunity, and how it informs the timeline of COVID-19 outbreaks this year.
A new study breaks down the risk prediction of death or hospitalization related to COVID-19 in adults following their vaccination.
September 28, 2021
The companies will be seeking emergency authorization for a lighter-dose mRNA vaccine for children aged 5 to
Data finds low risk for anaphylaxis, myocarditis, and other potential complications.
